Integrated BioPharma elects two Class I directors, ratifies Marcum as auditor at 2024 annual meeting

INTEGRATED BIOPHARMA INC

Elected Damon DeSantis as Class I director: 20,448,871 for, 142,036 withheld, 1,342,353 broker non-votes.
Elected Riva Sheppard as Class I director: 20,301,671 for, 289,236 withheld, 1,342,353 broker non-votes.
Ratified appointment of Marcum LLP as independent auditor for FY2025: 21,905,273 for, 9,287 against, 18,700 abstain.
Total shares voted: 21,933,260 of 30,099,610 entitled; quorum present.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.